CITIC Pharmaceuticals, under DFP oversight, became one of China leading pharma distribution and logistics companies. With a strong network, a premium portfolio of MNC drugs, and tracking systems at international standards, Citic was modeled to be the McKesson of China. DFP achieved this exit through M&A trade sale, in what stood as the largest healthcare deal in the PRC.